Innovent Biologics Raises $421 Million in Hong Kong IPO

Bookmark
(Bloomberg) -- Innovent Biologics Inc., a Chinese biotech firm backed by Temasek Holdings Pte, raised HK$3.3 billion ($421 million) after pricing its Hong Kong initial public offering near the top ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.